Wansheng pharmaceutical company in Bengbu, Anhui Province

Source: health sector April 23, 2015 Anhui Province Drug volume procurement has always been the focus of attention Recently, Bengbu City, Anhui Province Drug volume procurement has attracted the attention of the industry Yesterday (April 22), Bengbu Health Bureau announced the results of purchasing with volume, which basically reached the expected goal According to the results released by Bengbu Municipal Health Bureau, more than 20 kinds of drugs have won the bid in the inquiry purchase of a single variety with a volume, and the drug price has dropped by 25% 5 out of the city and 5 in the city and 10 distribution enterprises were selected as the bid winning suppliers through competitive negotiation and procurement More than 2600 kinds of drugs are involved in this centralized purchase of drugs Compared with the current average market price, the purchase of the same drugs in the amount of packing belt decreases by 17.24%, with a maximum decrease of 22.5%, and the amount of profit is more than 80 million yuan According to the expected target of volume purchase in Bengbu City, the volume purchase of 30 single varieties of drugs is required to achieve a 25% reduction; the volume purchase of clinical drugs involves more than 2600 varieties, with a minimum reduction of 15%, and 10 distributors are selected Outcome 1: 10 distributors were selected, with a minimum decrease of 15.05% and a maximum decrease of 22.5% Outcome 2: 21 varieties of clinical drug consumption purchase orders won the bid according to the results of "clinical drug consumption purchase by public medical institutions" in Bengbu City At the initial stage, 16 varieties of 13 enterprises were reviewed After the announcement of the bidding results, some single variety manufacturers contacted Bengbu public medical and health institutions' drug consumables and equipment centralized procurement office, and applied for approval to be listed in the transaction directory according to the inquiry requirements The procurement office finally agreed to the transaction of the production enterprise and varieties, and publicized them on the official website of the Health Bureau Policy Review on February 27, 2015, Anhui Provincial Department of Health issued the guidance on the volume purchase of medical consumables for public medical institutions in Anhui Province in 2015, which proposed that, on the premise of voluntary, equal transaction and consensus between the buyer and the seller, the volume price linkage should be implemented, the actual transaction price of drugs and high value consumables should be determined, and the volume purchase of single product should be implemented Subsequently, Bengbu health and Family Planning Commission formulated the implementation measures for centralized procurement of medical consumables and equipment of public medical and health institutions in Bengbu (Provisional), defining the subject, scope and cycle of procurement with volume According to the 5441 drug (product specification) price limit catalogues published by the provincial procurement platform, Bengbu City's drug centralized volume procurement can be divided into two ways: single variety volume inquiry procurement and packaging competitive negotiation procurement On April 19, Bengbu public medical institutions in Anhui Province issued a letter to relevant drug manufacturers of Bengbu City on volume purchase of single product, stipulating that the profit margin of each single product drug manufacturer or authorized agent in Bengbu City shall not be less than 25% of the guaranteed payment price of traditional Chinese medicine in the provincial drug price limit catalogue Otherwise, all the drugs of its manufacturing enterprises shall not be sold in all the public medical institutions of Bengbu City permanently From the purchasing results, Bengbu City basically completed the initial goal of centralized drug procurement Bengbu Municipal Health Bureau also said that it will issue supporting documents such as the measures for the supervision and implementation of centralized and volume purchasing of pharmaceutical consumables and equipment to strengthen the supervision and management of bid winning enterprises, distribution enterprises and medical and health institutions.